Prelude Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-54,578
| Closed | -$166K | – | 1203 |
|
|
2023
Q4 | $166K | Sell |
54,578
-9,630
| -15% | -$29.4K | 0.01% | 851 |
|
|
2023
Q3 | $193K | Buy |
64,208
+40,130
| +167% | +$120K | 0.01% | 773 |
|
|
2023
Q2 | $90.1K | Sell |
24,078
-4,422
| -16% | -$16.5K | 0.01% | 822 |
|
|
2023
Q1 | $95.5K | Buy |
+28,500
| New | +$95.5K | 0.01% | 859 |
|
|
2022
Q3 | – | Sell |
-10,196
| Closed | -$72K | – | 1483 |
|
|
2022
Q2 | $72K | Sell |
10,196
-4
| -0% | -$28 | ﹤0.01% | 1240 |
|
|
2022
Q1 | $74K | Buy |
+10,200
| New | +$74K | ﹤0.01% | 1159 |
|